Workflow
嗜黏蛋白阿克曼氏菌Akk11
icon
Search documents
体重管理新突破:“减重密钥”Akk11益生菌登场
Zhong Guo Shi Pin Wang· 2025-06-16 07:52
Core Insights - Obesity is one of the top ten chronic diseases globally, with projections indicating that by 2030, the overweight and obesity rate among adults in China will reach 70.5%, and among children, it will reach 31.8% [1] - Traditional weight loss methods often lead to rebound effects and poor experiences, highlighting the need for more scientific and instinctive solutions [1] - Akk11, derived from the gut microbiota of healthy infants in pollution-free highland areas, represents a new approach to weight management by balancing metabolism and promoting gentle weight loss [1] Company and Product Development - Microbiome company has established an industry-leading fully anaerobic automated production line for Akk11, utilizing advanced technologies such as fully automated anaerobic fermentation systems and high-precision centrifugation [2] - Akk11's specifications include 600 billion AFU/gram for live bacteria and 10 trillion TFU/gram for inactivated bacteria, with an annual production capacity exceeding 200 tons, meeting market demand [2] - Akk11 is expected to receive GRAS safety certification in the United States in 2024 [2][5] Clinical Research and Efficacy - Clinical studies indicate that Akk11 effectively improves body fat, metabolic levels, and emotional health, functioning through appetite control, metabolic activation, and enhanced energy expenditure [1] - Akk11 also regulates oxidative stress, improves sleep and emotional health, creating a positive feedback loop between metabolic improvement and mental well-being [1] Market Potential and Future Outlook - Akk11 has garnered global attention in the health industry, particularly at the 2025 Natural Products Expo West in the United States, showcasing its potential beyond weight loss, including benefits for blood pressure stability and bone health [6] - The product has multiple patents and clinical research supporting its effects on blood lipid regulation, liver protection, and anti-aging, indicating a broad application prospect [6] - The company aims to continue focusing on promoting human health and environmental sustainability through high-quality microbiota [7]